Cancer chemoprevention through interruption of multistage carcinogenesis: the lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer
F. Marks et G. Furstenberger, Cancer chemoprevention through interruption of multistage carcinogenesis: the lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer, EUR J CANC, 36(3), 2000, pp. 314-329
Whilst in the early stages. neoplastic development is predominantly trigger
ed by environmental genotoxic and non-genotoxic carcinogens, tumour progres
sion becomes more and more autonomous at later stages. In this contest a dy
sregulation of arachidonic acid metabolism seems to play a disastrous role.
Conversely, non-steroidal anti-inflammatory drugs (NSAIDs) rank among the
most potent and most promising agents for cancer chemoprevention probably b
ecause of their ability to inhibit prostaglandin biosynthesis, in particula
r, at the level of the 'pro-inflammatory' enzyme cyclooxygenase-2 (COX-2).
A pathological overexpression of COX-2 resulting in excessive prostaglandin
production has been found already in early stages of carcinogenesis and se
ems to be a consistent feature of neoplastic development in a wide variety
of tissues. COX-2 overexpression is thought to occur along signalling pathw
ays of inflammation and tissue repair which become activated in the course
of tumour promotion and, due to autocrine and auto-stimulatory mechanisms,
finally lead to some autonomy of tumour development (self-promotion). Prost
aglandins formed along a dysregulated COX pathway have been shown to mediat
e tumour promotion in animal experiments and may play a role, in addition,
in other processes involved in tumour growth such as angiogenesis, metastas
is and immunosuppression. Moreover, genotoxic byproducts such as organic fr
ee radicals, ri active oxygen species and malondialdehyde produced in the c
ourse of prostanoid biosynthesis may contribute to genetic instability (mut
ator phenotype) of neoplastic cells thereby promoting malignant progression
. Such mixtures of physiologically highly active mediators and genotoxic by
products are, in addition, formed along the various lipoxy-genase-catalysed
pathways of arachidonic acid metabolism some of which also become dysregul
ated during tumour development and, therefore, provide novel targets of fut
ure chemopreventive approaches, (C).: 2000 Elsevier Science Ltd. All rights
reserved.